DOCTORS'
Medical Case Studies
(excluding small cell carcinoma) were treated with irinotecan , 65 mg/m2, and cisplatin , 30 mg/m2, administered weekly for 2 ... JW, Earle CC, Michelini A, Fuchs CS.A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors. Dig ...
or on or off a clinical trial, bevacizumab plus or minus irinotecan, or capecitablne . While the experience with any of these is ... temozolomide (oral), oral etoposide (oral), bevacizumab, irinotecan, capecitablne, pain control. Treatments : ...
proceed with bevacizumab plus or minus temozolomide or irinotecan , either on or off an experimental, clinical trial. ... gadolinium texaphyrin, bevacizumab, temozolomide, irinotecan. Treatments : pharmacologic therapy, radiotherapy, ...
(IVIG) Intravitreal Bevacizumab Ipilimumab Irinotecan Iron chelating agents Iron supplements (IV) Isoptin ...
JJ, Desjardins A, et al, Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res. 2007 Feb ... alkylating agent, temozolomide, Avastin, bevacizumab, irinotecan, Tarceva, rapamycin, EGFR inhibitors, mTOR inhibitors, Gleevec, ...
JJ, Desjardins A, et al, Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res. 2007 Feb ... , bevacizumab, Tarceva , rapamycin , irinotecan , EGFR inhibitors , mTOR inhibitors , Gleevec, ...
by PET-CT. An year and a half later, treatment with Irinotecan and Erbitux was initiated with partial remission up until the last 2 ...
cancer, the others being 5-fluorouracil, oxaliplatin, irinotecan and cetuximab. While bevacizumab is not active as a single ... Avastin (bevacizumab), 5-fluorouracil, oxaliplatin, irinotecan, cetuximab, capecitabine. (Case ...
doublet combinations incorporating docetaxel, oxaliplatin, irinotecan, capecitabine, or S-1 , such as have been reported in recent years ... University Hospital Gasthuisberg, Leuven, Belgium; or irinotecan, docetaxel and oxaliplatin as reported in Br J Cancer 2007, by ...